<DOC>
	<DOCNO>NCT01864304</DOCNO>
	<brief_summary>Williams Syndrome ( WS ) genetic syndrome feature may include vascular stenosis , neuro-developmental change , variety endocrine metabolic abnormality , include impaired glucose metabolism abnormal body composition . Approximately 75 % adult WS impair glucose tolerance diabetes oral glucose tolerance testing ( OGTT ) . In addition , clinical observation preliminary data suggest increase overall body fat individual , well relative increase fat deposition low extremity . However , glucose lipid metabolism WS remain incompletely characterize . The purpose current study carefully describe glucose metabolism lipid parameter people WS .</brief_summary>
	<brief_title>Fat Distribution Glucose Metabolism Williams Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Williams Syndrome</mesh_term>
	<criteria>Inclusion Criteria 1 . M F age 1470yo 2 . Diagnosis WS confirm FISH chromosomal microarray ( WS ) 3 . Availability parent guardian participate consent process ( WS , control &lt; 18yo ) Exclusion Criteria 1 . History weight loss surgery liposuction 2 . Use weightlowering drug 3 . Positive urine pregnancy test ( female ) 4 . Obesity abnormal fat distribution due know secondary cause ( except WS ) Cushing syndrome , HIVinfection , etc . 5 . Known diabetes preclude administration OGTT participation aspect study .</criteria>
	<gender>All</gender>
	<minimum_age>14 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Williams Syndrome</keyword>
</DOC>